Will a therapy that substantially slows down or reverses the aging process in humans be developed before 2040?

There is a 60.12% chance a therapy to slow aging will be developed by 2040.

The prediction market shows a majority belief, at 60.12%, that a therapy to significantly slow or reverse aging will be developed before 2040. The Pulse AI also reflects a similar sentiment, albeit slightly lower at 57.12%. With a confidence level of 50/100 and a fair pricing edge, the market appears balanced in its expectations.

• 1 Current market sentiment favors the development of aging therapies.
• 2 The probability indicates moderate optimism among participants.
• 3 Historical trends show increasing interest in longevity research.
• 4 Liquidity in the market suggests active participation and engagement.
• 5 Time pressure is significant with less than 14 years until the deadline.